PET imaging test for solid tumors using FAP-2286
Part of Cancer clinical trials.
This Phase 1 study tests a special imaging scan (using FAP-2286) to see solid tumors in people who have already been diagnosed. It may help doctors better detect where cancer is in the body and how to plan treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have a confirmed solid tumor diagnosis (not just suspected cancer)
- Have cancer in one of these groups: metastatic disease, no known spread, or high-risk early disease where spread would change treatment plans
- Be willing and able to sign informed consent and follow study steps
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial tests a special imaging technique that may help doctors see and stage solid tumors more precisely. It uses a targeted radioactive tracer to highlight cancer cells during PET and SPECT scans, which could help plan better treatment.
This study tests a new type of imaging agent (called a tracer) that helps PET scans see tumors more clearly. It may help doctors find and monitor cancer better.
This trial tests an experimental PET imaging drug, called 68Ga-GP-01, to see if it can help show tumors and any spread of the cancer. The study will give you the imaging drug, then take a PET/CT scan. You may join if you have a solid tumor and are scheduled for surgery or a laparoscopic exploration to confirm the cancer.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.
Hear when a new Metastatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.